Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19243000 | 0.79 | ALDH1A1 (0.40) | MAPTALDH1A1CA12CA1CA2 | |
| SCHEMBL11175185 | 0.77 | ALDH1A1 (0.44) | ABCB11MAPK1ALDH1A1 | |
| SCHEMBL25275373 | 0.77 | CA12 (0.39) | HTR2AKDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL31439746 | 0.74 | ALDH1A1 (0.43) | MAPK1SMN1; SMN2ALDH1A1CA12CA1 | |
| SCHEMBL11253139 | 0.74 | ADRA1A (0.57) | ABCB11HTR2AMAPK1CA12CA1 | |
| SCHEMBL11983792 | 0.73 | ALDH1A1 (0.48) | KDM4EMAPK1SMN1; SMN2ALDH1A1CA12 | |
| SCHEMBL20148897 | 0.73 | ALDH1A1 (0.48) | KDM4EMAPK1SMN1; SMN2ALDH1A1CA12 | |
| SCHEMBL16617643 | 0.73 | TSHR (0.38) | KDM4EMAPK1SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL4661123 | 0.73 | PPARG (0.48) | KDM4EMAPK1MAPTCA12CA1 | |
| SCHEMBL7198348 | 0.73 | CYP3A4 (0.46) | MAPK1SMN1; SMN2USP2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9567277-B2 | Reagent for enhancing generation of chemical species | TOYO GOSEI CO., LTD. (JP) | 2017-02-14 | — | — | US | disclosed |
| US-20150099893-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | OSAKA UNIVERSITY (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099893-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | PPOX, CYBB, CBR3 | ABCB11 4784/4885HTR2A 4156/4885KDM4E 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.